Recent taxonomic developments with candida and other opportunistic yeasts

Current Fungal Infection Reports

Volumn 6, Issue 3, 2012, Pages 170-177

  Brandt, Mary E ^a   Lockhart, Shawn R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Antifungal resistance; Candida species; Cryptococcus species; Emerging fungal infections; Non albicans Candida; Trichosporon species; Yeast infection

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; PYRROLE DERIVATIVE; TUMOR NECROSIS FACTOR INHIBITOR;

ANTIFUNGAL RESISTANCE; ARTICLE; BASIDIOMYCETES; BLOOD CULTURE; BROTH DILUTION; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA FAMATA; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA METAPSILOSIS; CANDIDA ORTHOPSILOSIS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CHLAMYDOSPORE; CLAVISPORA; CLAVISPORA LUSITANIAE; CRYPTOCOCCUS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; DENMARK; DIPODASCUS CAPITATUS; DNA SEQUENCE; FUNGEMIA; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GALACTOMYCES GEOTRICHUM; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; KLUYVEROMYCES MARXIANUS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MENINGITIS; MYCOLOGY; MYCOSIS; NONHUMAN; PHYLOGENY; PICHIA ANOMALA; PICHIA GUILLIERMONDII; PICHIA JADINII; RHEUMATOID ARTHRITIS; RHODOTORULA GLUTINIS; SACCHAROMYCES CEREVISIAE; SKIN INFECTION; TAXONOMY; TELEOMORPH; TIME OF FLIGHT MASS SPECTROMETRY; TRICHOSPORON; TRICHOSPORONOSIS; YARROWIA LIPOLYTICA; YEAST;

EID: 84869118106     PISSN: 19363761     EISSN: 1936377X     Source Type: Journal    
DOI: 10.1007/s12281-012-0094-x     Document Type: Article

References (36)

1. van Belkum A, et al. Biomedical mass spectrometry in today's and tomorrow's clinical microbiology laboratory. J Clin Microbiol. 2012;50:1513-7.
2. Taylor JW, et al. Phylogenetic species recognition and species concepts in fungi. Fungal Genet Biol. 2000;31:21-32. This paper describes the rationale behind the concept of a phylogenetic species.
3. Hawksworth DL. Pandora's mycological box: Molecular sequences vs. morphology in understanding fungal relationships and biodiversity. Rev Iberoam Micol. 2006;23:127-33.
4. Clinical and Laboratory Standards Institute. MM18-A: Interpretive criteria for identification of bacteria and fungi by DNA target sequencing; Approved Guideline. Wayne: CLSI; 2007. Lists the DNA targets currently used to identify most common fungal species.
5. Hawksworth DL. Managing and coping with names of pleomorphic fungi in a period of transition. Mycosphere. 2012;3:52-64. Explains the rationale behind the end of the "one fungus-two names" taxonomic rule.
6. Miceli MH, Diaz JA, Lee SA. Emerging opportunistic yeast infections. Lancet Infect Dis. 2011;11:142-51.
7. Schmid J, et al. Increased mortality in young candidemia patients associated with presence of a Candida albicans general-purpose genotype. J Clin Microbiol. 2011;49:3250-6.
8. Ells R, Kock JLF, Pohl CH. Candida albicans or Candida dubliniensis? Mycoses. 2011;54:1-16.
9. Lockhart SR. Do hospital microbiology laboratories still need to distinguish Candida albicans from Candida dubliniensis? J Clin Microbiol. 2011;49:4415.
10. Romeo O, Criseo G. Candida africana and its closest relatives. Mycoses. 2011;54:475-86.
11. Falagas ME, Roussos N, Vardakas KZ. Relative frequency of albicans and the various non-albicans Candida species among candidemia isolates form inpatients in various parts of the world: A systematic review. Int J Infect Dis. 2010;14:e954-66.
12. Warren TA, et al. Candida bracarensis bloodstream infection in an immunocompromised patient. J Clin Microbiol. 2010;48:4677-9.
13. Yang YL, et al. Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazole. Plos One. 2012;7:e34609.
14. Kurtzman CP, Fell JW, Boekhout T, editors. The yeasts: A taxonomic study. 5th ed. London: Elsevier; 2011. The standard manual for yeast taxonomy and identification.
15. Savini V, et al. What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast. Mycoses. 2011;54:434-41.
16. Jensen RH, Arendrup MC. Candida palmioleophila: Characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species. J Clin Microbiol. 2011;49:549-56.
17. Paredes K, et al. Molecular identification and antifungal susceptibility of clinical isolates of Candida rugosa species complex and proposal of the new species Candida neorugosa. J Clin Microbiol. 2012. doi:10.1128/JCM.00688-12.
18. Taverna CG, et al. First case report of bloodstream infection due to a Candida species closely related to the novel species Candida pseudorugosa. J Clin Microbiol. 2012;50:2165-9.
19. Kurtzman CP. Phylogeny of the ascomycetous yeasts and the renaming of Pichia anomala to Wickerhamomyces anomalus. Antonie van Leeuwenhoek. 2011;99:13-23.
20. Al-Sweih N, et al. Kodamaea ohmeri as an emerging pathogen: A case report and review of the literature. Med Mycol. 2011;49:766-70.
21. Pfüller R, et al. A novel flucytosine-resistant yeast species, Candida pseudoaaseri, causes disease in a cancer patient. J Clin Microbiol. 2011;49:4195-202.
22. Adam H, et al. Identification of a new species, Candida subhashii, as a cause of peritonitis. Med Mycol. 2009;47:305-11.
23. Lee WG, et al. First three reported cases of nosocomial fungemia caused by Candida auris. J Clin Microbiol. 2011;49:3139-42.
24. Bovers M, Hagen F, Boekhout T. Diversity of the Cryptococcus neoformans-Cryptococcus gattii species complex. Rev Iberoam Micol. 2008;25:S4-S12.
25. Kwon-Chung KJ, Polacheck I, Bennett JE. Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol. 1982;15:535-7.
26. McTaggart L, et al. Rapid identification of Cryptococcus neoformans var. grubii, C. neoformans var. neoformans, and C. gattii by use of rapid biochemical tests, differential media, and DNA sequencing. J Clin Microbiol. 2011;49:2522-7. A very helpful description of the most recent ways to separate these two species.
27. MeyerW, et al. Consensusmulti-locus typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol. 2009;47:561-70.
28. Ngamskulrungroj F, et al. Genetic diversity of the Cryptococcus species complex suggests that Cryptococcus gattii deserves to have varieties. PLoS One. 2009;4:e5862.
29. Byrnes EJ, et al. Cryptococcus gattii: An emerging fungal pathogen infecting humans and animals. Microbes Infect. 2011;13:895-907.
30. Harris J, et al. Cryptococcus gattii in the United States: Clinical aspects of infection with an emerging pathogen. Clin Infect Dis. 2011;53:1188-95. Describes clinical aspects of patients diagnosed with C. gattii infection.
31. Iqbal N, et al. Correlation of genotype and in vitro susceptibilities of Cryptococcus gattii strains from the Pacific Northwest of the United States. J Clin Microbiol. 2010;48:539-44.
32. Lockhart SR, et al. Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: Correlation of molecular type and in vitro susceptibility. Diagn Microbiol Infect Dis. 2012. doi:10.1016/ j.diagmicrobio.2012.02.018.
33. Chagas-Neto TC, Chaves GM, Colombo AL. Update on the genus Trichosporon. Mycopathologia. 2008;166:121-32.
34. Hickey PW, et al. Trichosporon mycotoxinivorans, a novel respiratory pathogen in patients with cystic fibrosis. J Clin Microbiol. 2009;47:3091-7.
35. Chitasombat MN, et al. Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer. J Infect. 2012;64:68-75.
36. Gaitanis G, et al. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev. 2012;25:106-41.